| abstract |
Compounds of formula (I) n n n n n n n n n n n n wherein R 1 is a phenylcarbonylmethyl group wherein the phenyl moiety is substituted by R 10 and R 11 and R 2 to R 4 and R 10 and R 1l are defined as in the claims, or the prodrugs or salts thereof, particularly the physiologically acceptable salts thereof, pharmaceutical compositions containing these compounds, and methods of treating type II diabetes mellitus and obesity using these compounds. |